A prospective open labeled clinical trial to evaluate the efficacy and safety of â??HAIRAL 7â?? in hair regrowth and in the treatment of dandruff and hair loss in female and male patients. - HAIRAL 7 study

ABS LABORATORIES0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•ï??Males and females of age group 18-40 years
•ï??Subjects who are suffering from mild to moderate hair loss and/or Subjects suffering from mild to moderate dandruff.
•ï??Subjects who are willing to give written informed consent

•ï??Any dermatological condition of the scalp other than hair loss and /or dandruff.
•ï??Prior use of scalp hair growth treatment (e.g., finasteride, minoxidil) within 6 months
•ï??Any prior hair growth procedures (e.g., hair transplant or laser)
•ï??History of alcohol or drug addiction
•ï??History of skin allergy
•ï??Regular use of medication which might interfere with the results of the study
•ï??Subject had used phytotherapy (e.g., saw palmetto) within eight weeks prior to baseline.
•ï??Any active skin infection in the scalp area or scarring in the target area.
•ï??Photosensitivity to laser light.
•ï??Subjects with psoriasis/seborrheic dermatitis
•ï??Medications with anti-androgenic properties (e.g., cyproterone acetate, spironolactone, ketoconazole, flutamide, bicalutamide), topical estrogen, tamoxifen, anabolic steroids, oral glucocorticoids (or other medications at the discretion of the Investigator.(these are the Medications for hair loss)
•ï??History of thyroid or other medical condition including polycystic ovary syndrome that might influence hair growth and loss, at the discretion of the Investigator.
•ï??Subject had ever received radiation therapy to the scalp, or had chemotherapy within the past year

发起方

ABS LABORATORIES